Skip to content

Clinical trials

Terminated Phase 1/2 trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Status: Terminated Country / region: Belgium Clear all

84 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20054
20062
20073
20082
20092
20103
20111
20124
20135
20143
20153
20163
20177
201811
201910
20207
20216
20225
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated84

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer6
Genmab5
Incyte Corporation4
Cliniques universitaires Saint-Luc- Université Catholique de Louvain3
Novartis Pharmaceuticals3
Amgen2
BioMarin Pharmaceutical2
Bristol-Myers Squibb2
Eli Lilly and Company2
Hoffmann-La Roche2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma9
Breast Neoplasms8
Carcinoma, Non-Small-Cell Lung5
Neoplasm Metastasis5
Recurrence5
Colorectal Neoplasms4
Lymphoma, Follicular4
Lymphoma, Large B-Cell, Diffuse4
Lymphoma, Non-Hodgkin4
Carcinoma, Ovarian Epithelial3

Trials

Showing 1 to 25 of 84. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.